Based on our present and previous findings [39] the question arises as to how much different preparations of tau, either recombinant or AD patient-derived, containing varying amounts and forms of synaptic plasticity-disrupting tau are representative of tau assemblies present in AD brain. Here, MAPT is linked to Alzheimer disease.